These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 951457)

  • 41. Morphine training dose: a determinant of stimulus generalization to narcotic antagonists in the rat.
    Shannon HE; Holtzman SG
    Psychopharmacology (Berl); 1979 Mar; 61(3):239-44. PubMed ID: 156379
    [No Abstract]   [Full Text] [Related]  

  • 42. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of morphine and naloxone on thresholds of ventral tegmental electrical self-stimulation.
    van Wolfswinkel L; van Ree JM
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):84-92. PubMed ID: 4047179
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Opiate mixed agonist-antagonist interactions with histamine antagonists vs. morphine.
    Hui FW; Sun CL; Hanig JP
    Neurobehav Toxicol Teratol; 1985; 7(5):443-7. PubMed ID: 4080063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pharmacological actions of eptazocine (l-1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1,H-4-benzazonine). 4. Antagonistic action of naloxone on eptazocine analgesia].
    Nabeshima T; Yamada S; Yamaguchi K; Matsuno K; Kameyama T; Sakakibara S; Matsumoto S
    Nihon Yakurigaku Zasshi; 1983 May; 81(5):411-20. PubMed ID: 6629212
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence for a supraspinal analgesic effect with cyclazocine and pentazocine.
    Sasson S; Kornetsky C
    Life Sci; 1986 Jan; 38(1):21-6. PubMed ID: 3941590
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discriminative response control by naloxone in morphine pretreated rats.
    Miksic S; Sherman G; Lal H
    Psychopharmacology (Berl); 1981; 72(2):179-84. PubMed ID: 6782608
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Actions and interactions of amphetamine on self-stimulation in rats.
    Aulakh CS; Pradhan SN
    Pharmacol Biochem Behav; 1979 Sep; 11(3):351-4. PubMed ID: 41267
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Opioid agonists/antagonists in morphine-tolerant squirrel monkeys.
    Dykstra LA; Picker MJ; Powell KR
    Pharmacol Biochem Behav; 1990 Jul; 36(3):639-44. PubMed ID: 1974067
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure.
    O'Callaghan JP; Holtzman SG
    J Pharmacol Exp Ther; 1975 Mar; 192(3):497-505. PubMed ID: 1168252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The interaction of d-amphetamine and naloxone differs for rats trained on separate fixed-interval or fixed-ratio schedules of reinforcement.
    Andrews JS; Holtzman SG
    Pharmacol Biochem Behav; 1987 Jan; 26(1):167-71. PubMed ID: 3562487
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyclazocine and pentazocine as N-methylaspartate antagonists on cat and rat spinal neurons in vivo.
    Church J; Lodge D
    J Pharmacol Exp Ther; 1990 May; 253(2):636-45. PubMed ID: 2160004
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selective antagonism of the error-increasing effect of morphine by naloxone in a repeated-acquisition task.
    Thompson DM; Moerschbaecher JM
    J Exp Anal Behav; 1981 Nov; 36(3):371-80. PubMed ID: 7310262
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of ketocyclazocine and ethylketocyclazocine on electric shock titration.
    Dykstra LA
    Eur J Pharmacol; 1983 Oct; 94(1-2):19-26. PubMed ID: 6360694
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute effects of opiate agonists, partial agonists and antagonists on brain monoamines in the rat.
    Fennessy MR; Laska FJ
    Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):60-70. PubMed ID: 485705
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interactions between narcotic agonists, partial agonists andd antagonists evaluated by punished an unpunished behavior in the rat.
    Snell D; Harris RA
    Psychopharmacology (Berl); 1982; 76(2):177-81. PubMed ID: 6281840
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Involvement of mu-opioid receptors in the antitussive effects of pentazocine.
    Kamei J; Katsuma K; Kasuya Y
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):203-8. PubMed ID: 1314961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of narcotics and narcotic antagonists on operant behavior.
    McMillan DE
    Adv Biochem Psychopharmacol; 1973; 8(0):345-59. PubMed ID: 4604406
    [No Abstract]   [Full Text] [Related]  

  • 59. Selected opioids and responding for intracranial reinforcement.
    Reid LD; Hubbell CL; Dunn LL; Hunter GA; Costa T
    Neuropeptides; 1985 Feb; 5(4-6):331-4. PubMed ID: 3889692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dopaminergic involvement in the mechanism of action of pentazocine.
    Hernández LL; Appel JB
    Behav Neural Biol; 1979 Aug; 26(4):384-400. PubMed ID: 227353
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.